Vanguard Personalized Indexing Management, LLC
Position in VTRS — Viatris Inc
CIK 1767306
OAKLAND, CA
Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,761,427
+$263,264 QoQ
Shares Held
278,418
-0.9% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 78.09552543298206.ToString("F0")%
Shared 0.ToString("F0")%
None 21.904474567017935.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vanguard Personalized Indexing Management, LLC holds $32,147,521 across 27 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,491 | $5,732,121 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
336,578 | $4,661,605 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,809 | $4,630,580 | |
| 4 | VTRS |
Viatris Inc
This page
|
278,418 | $3,761,427 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
132,089 | $2,446,288 | |
| 6 | HLN |
Haleon plc
|
208,415 | $2,086,234 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
79,946 | $1,913,107 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
10,642 | $1,401,977 |
All Filings in VTRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,761,427 | 278,418 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,498,163 | 280,977 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,750,289 | 277,807 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,381,702 | 266,708 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,469,437 | 168,707 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,259,787 | 181,509 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,908,765 | 164,407 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,414,034 | 133,023 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,789,614 | 149,884 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,499,336 | 230,779 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,259,220 | 127,710 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,107,031 | 110,925 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $4,008,442 | 416,678 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $507,194 | 45,570 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $479,156 | 56,239 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $448,471 | 42,834 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $327,400 | 30,092 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $240,387 | 17,767 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $190,363 | 14,049 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $212,149 | 14,846 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $144,743 | 10,361 | Shares | Sole | 2021-04-28 | |
| No filing history on record for this holder in this stock. | ||||||